Simplex Trading, LLC Gt Biopharma, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$0.22 - $0.28 $33 - $42	-150 Reduced 33.04%	304 $0
Q3 2023 Nov 01, 2023	BUY	$0.24 - $0.35 $12 - $18	54 Added 13.5%	454 $0
Q2 2023 Aug 04, 2023	BUY	$0.22 - $0.55 $88 - $220	400 New	400 $0
Q4 2022 Feb 02, 2023	SELL	$0.89 - $58.2 $642 - $42,020	-722 Reduced 72.34%	276 $0
Q3 2022 Nov 04, 2022	SELL	$1.81 - $56.1 $1,648 - $51,107	-911 Reduced 47.72%	998 $1,000
Q2 2022 Aug 03, 2022	SELL	$1.64 - $3.11 $6,204 - $11,765	-3,783 Reduced 66.46%	1,909 $5,000
Q1 2022 May 02, 2022	SELL	$2.6 - $3.3 $1,606 - $2,039	-618 Reduced 9.79%	5,692 $16,000
Q4 2021 Feb 23, 2022	BUY	$3.05 - $7.08 $19,041 - $44,200	6,243 Added 9317.91%	6,310 $19,000
Q2 2021 Aug 12, 2021	BUY	$7.19 - $18.96 $481 - $1,270	67 New	67 $1,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.